DFT383 in Pediatric Participants With Nephropathic Cystinosis

Clinical trial NCT06910813 · RECRUITING

Trial details

NCT number: NCT06910813
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Nephropathic Cystinosis

Start date: 2025-06-02
Primary completion: 2031-05-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.